See the pattern, not just the headline.

Waypoint Bio raises $20M to expand its AI platform and clinical capabilities

Waypoint Bio closed a $20 million Series A led by Amplify Partners. The company plans to expand its AI and spatial-biology platform, build clinical-development capabilities and move its lead cell-therapy programs toward trials, while adding former CTRL-Labs and Meta Reality Labs leader Patrick Kaifosh as CTO.